Form 4: Cross Country Healthcare CFO Equity Transaction
Statement of Changes in Beneficial Ownership
CFO William J. Burns acquired 47,873 restricted shares and withheld 5,313 shares for tax obligations.
Summary
- CFO William J. Burns received a grant of 47,873 restricted shares of common stock on March 31, 2026.
- A total of 5,313 shares were withheld by the company to satisfy tax withholding obligations related to the vesting of restricted stock.
- Following these transactions, the reporting person holds a total of 336,438 shares of common stock.
- The newly granted restricted shares are scheduled to vest in three equal annual installments starting March 31, 2027.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a routine administrative filing regarding executive compensation with no material impact on the company's financial outlook.
Positives
- The CFO maintains a significant equity stake of 336,438 shares, aligning interests with shareholders.
Negatives
- The transaction involved the withholding of shares to cover tax liabilities, which is a standard but routine reduction in total holdings.
Risks
- The value of the equity compensation is subject to market volatility in the company's share price.
Future Outlook
The filing does not provide forward-looking financial guidance, focusing solely on executive equity compensation.
Industry Context
StockSavvy.ai notes that executive equity grants are standard practice in the healthcare staffing industry to ensure long-term retention and alignment with shareholder value creation.
Comparison to Industry Standards
- The use of restricted stock units (RSUs) with multi-year vesting schedules is consistent with compensation practices at peers like AMN Healthcare and ASGN Incorporated.
Stakeholder Impact
- Shareholders may view the long-term vesting schedule as a positive sign of management commitment to the company's future performance.
Next Steps
- Vesting of the first installment of the new restricted stock grant on March 31, 2027.
Key Dates
| Date | Description |
|---|---|
| 03/31/2026 | Transaction date for share acquisition and tax withholding. |
| 03/31/2027 | First vesting date for the new restricted stock grant. |
| 03/31/2028 | Second vesting date for the new restricted stock grant. |
| 03/31/2029 | Final vesting date for the new restricted stock grant. |
Keywords
CCRN, Cross Country Healthcare, Form 4, Insider Trading, Equity Compensation, CFO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.